Loading…
Monday September 30, 2024 2:30pm - 3:00pm EDT
Even the best pre-clinical work doesn’t necessarily predict what will happen in the clinic, underscoring the imperative to take multiple shots on goal in building a pipeline.
 
This presentation will discuss:
• Perspective on oncology drug development challenges and successes over the last decade, highlighting examples of leading with science to catapult innovation in cancer care.
• How efficiently pursuing clinical proof-of-concept (PoC) allows evaluation of multiple shots on goal with modest incremental investment and cues decision-making regarding later-stage development.
• How reduced reliance on external CROs and has expedited the drug development process, even with global clinical trials, without cutting corners for patient care.
Speakers
avatar for Mark Lanasa, MD, PhD

Mark Lanasa, MD, PhD

Chief Medical Officer, Solid Tumors, BeiGene
Mark Lanasa, M.D., Ph.D., joined the company in February 2022 as Senior Vice President, Chief Medical Officer for Solid Tumors. Prior to joining BeiGene, Dr. Lanasa served as Vice President and Global Clinical Head, Late Development Oncology at AstraZeneca from 2019 to 2022. He previously... Read More →
Monday September 30, 2024 2:30pm - 3:00pm EDT
The Westin Boston Seaport District

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link